Michael H. Davidson

Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk

A. Goldberg, H. Bays, D. Kallend, 2012, Diabetes, obesity & metabolism.